[Pharmacological and toxicological side effects of antifibrillatory substances].
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000633:toxicity; D001341:Autonomic Nervous System; D002463:Cell Membrane Permeability / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010672:Phenytoin / Q000494:pharmacology; D010946:Plants, Medicinal; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011926:Rauwolfia / Q000494:pharmacology; D011930:Reaction Time; D013034:Sparteine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D014439:Tyramine / Q000037:antagonists & inhibitors
D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D013034:Sparteine; D010672:Phenytoin; D011802:Quinidine; D011342:Procainamide; D000109:Acetylcholine; D014439:Tyramine
Pharmakolische und toxikologische Begleiterscheinungen der antifibrillatorischen Substanzen.